SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cell MedX Corp. – ‘10-Q’ for 11/30/22 – ‘EX-101.LAB’

On:  Friday, 5/19/23, at 1:48pm ET   ·   For:  11/30/22   ·   Accession #:  1393905-23-233   ·   File #:  0-54500

Previous ‘10-Q’:  ‘10-Q’ on 4/19/23 for 8/31/22   ·   Next:  ‘10-Q’ on 6/29/23 for 2/28/23   ·   Latest:  ‘10-Q’ on 4/15/24 for 2/29/24   ·   26 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/19/23  Cell MedX Corp.                   10-Q       11/30/22   53:2.4M                                   Empire Stock Transf… Inc

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Cell Medx Corp. - Form 10-Q SEC Filing              HTML    555K 
 2: EX-10.67    Loan Agreement Dated April 11, 2023, Among Cell     HTML     21K 
                Medx Corp. and Amir Vahabzadeh                                   
 3: EX-10.68    Loan Agreement Dated April 25, 2023, Among Cell     HTML     21K 
                Medx Corp. and David Jeffs                                       
 4: EX-31.1     Certification of Principal Executive Officer        HTML     19K 
 5: EX-31.2     Certification of Principal Financial Officer        HTML     19K 
 6: EX-32.1     Certification of Principal Executive Officer        HTML     16K 
 7: EX-32.2     Certification of Principal Financial Officer        HTML     16K 
13: R1          Document and Entity Information                     HTML     65K 
14: R2          Condensed Consolidated Balance Sheets               HTML     85K 
15: R3          Condensed Consolidated Balance Sheets -             HTML     23K 
                Parenthetical                                                    
16: R4          Condensed Consolidated Statements of Operations     HTML     84K 
17: R5          Condensed Consolidated Statement of Stockholders'   HTML     80K 
                Deficit                                                          
18: R6          Condensed Consolidated Statements of Cash Flows     HTML     70K 
19: R7          Organization and Nature of Operations               HTML     22K 
20: R8          Related Party Transactions Disclosure               HTML     36K 
21: R9          Notes and Advances Payable Disclosure               HTML     39K 
22: R10         Other Current Assets Disclosure                     HTML     18K 
23: R11         Equipment Disclosure                                HTML     23K 
24: R12         Revenue Disclosure                                  HTML     28K 
25: R13         Notes and Advances Payable Disclosure, Current      HTML     18K 
26: R14         Share Capital Disclosure                            HTML     40K 
27: R15         Subsequent Events Disclosure                        HTML     20K 
28: R16         Related Party Transactions Disclosure: Schedule of  HTML     24K 
                Amounts Due to Related Parties (Tables)                          
29: R17         Related Party Transactions Disclosure: Schedule of  HTML     26K 
                Transactions with Related Parties (Tables)                       
30: R18         Notes and Advances Payable Disclosure: Schedule of  HTML     29K 
                Loans and Advances Outstanding to Related Parties                
                (Tables)                                                         
31: R19         Equipment Disclosure: Change in book value of the   HTML     22K 
                equipment (Tables)                                               
32: R20         Revenue Disclosure: Schedule of Revenue and         HTML     28K 
                Associated Costs (Tables)                                        
33: R21         Share Capital Disclosure: Schedule of Stock Option  HTML     25K 
                Activity (Tables)                                                
34: R22         Share Capital Disclosure: Schedule of Warrant       HTML     25K 
                Activity (Tables)                                                
35: R23         Share Capital Disclosure: Schedule of Warrant       HTML     21K 
                Details (Tables)                                                 
36: R24         Organization and Nature of Operations (Details)     HTML     20K 
37: R25         Related Party Transactions Disclosure: Schedule of  HTML     29K 
                Amounts Due to Related Parties (Details)                         
38: R26         Related Party Transactions Disclosure: Schedule of  HTML     30K 
                Transactions with Related Parties (Details)                      
39: R27         Notes and Advances Payable Disclosure: Schedule of  HTML     29K 
                Loans and Advances Outstanding to Related Parties                
                (Details)                                                        
40: R28         Notes and Advances Payable Disclosure (Details)     HTML     68K 
41: R29         Other Current Assets Disclosure (Details)           HTML     20K 
42: R30         Equipment Disclosure: Change in book value of the   HTML     24K 
                equipment (Details)                                              
43: R31         Revenue Disclosure: Schedule of Revenue and         HTML     40K 
                Associated Costs (Details)                                       
44: R32         Notes and Advances Payable Disclosure, Current      HTML     25K 
                (Details)                                                        
45: R33         Share Capital Disclosure: Schedule of Stock Option  HTML     26K 
                Activity (Details)                                               
46: R34         Share Capital Disclosure: Schedule of Warrant       HTML     23K 
                Activity (Details)                                               
47: R35         Share Capital Disclosure: Schedule of Warrant       HTML     20K 
                Details (Details)                                                
48: R36         Subsequent Events Disclosure (Details)              HTML     30K 
51: XML         IDEA XML File -- Filing Summary                      XML     89K 
49: XML         XBRL Instance -- cmxc-20221130_htm                   XML    573K 
50: EXCEL       IDEA Workbook of Financial Reports                  XLSX     60K 
 8: EX-101.CAL  XBRL Calculations -- cmxc-20221130_cal               XML     51K 
 9: EX-101.DEF  XBRL Definitions -- cmxc-20221130_def                XML    213K 
10: EX-101.LAB  XBRL Labels -- cmxc-20221130_lab                     XML    383K 
11: EX-101.PRE  XBRL Presentations -- cmxc-20221130_pre              XML    334K 
12: EX-101.SCH  XBRL Schema -- cmxc-20221130                         XSD     95K 
52: JSON        XBRL Instance as JSON Data -- MetaLinks              188±   278K 
53: ZIP         XBRL Zipped Folder -- 0001393905-23-000233-xbrl      Zip    110K

‘EX-101.LAB’   —   XBRL Labels — cmxc-20221130_lab

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2023 [PPXC4Y912124VDCJENC7]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:fil="http://cellmedx.com/20221130" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance">
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
<link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_WarrantsGrantedJan2920202Member" xlink:label="fil_WarrantsGrantedJan2920202Member"/>
<link:label xlink:type="resource" xlink:label="lab_fil_WarrantsGrantedJan2920202Member" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Warrants Granted Jan 29, 2020(2) </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_WarrantsGrantedJan2920202Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Warrants Granted Jan 29, 2020(2), during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_WarrantsGrantedJan2920202Member" xlink:to="lab_fil_WarrantsGrantedJan2920202Member"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_NotesPayableRelatedPartiesOther" xlink:label="fil_NotesPayableRelatedPartiesOther"/>
<link:label xlink:type="resource" xlink:label="lab_fil_NotesPayableRelatedPartiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Notes payable related parties, other </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_NotesPayableRelatedPartiesOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the monetary amount of Notes payable related parties, other, as of the indicated date. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_NotesPayableRelatedPartiesOther" xlink:to="lab_fil_NotesPayableRelatedPartiesOther"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayable" xlink:label="us-gaap_LoansPayable"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_LoansPayable" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Principal outstanding </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayable" xlink:to="lab_us-gaap_LoansPayable"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_ConsultingFeesIncurredToACompanyControlledByOurCooMember" xlink:label="fil_ConsultingFeesIncurredToACompanyControlledByOurCooMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_ConsultingFeesIncurredToACompanyControlledByOurCooMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Consulting fees incurred to a company controlled by our COO </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_ConsultingFeesIncurredToACompanyControlledByOurCooMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Consulting fees incurred to a company controlled by our COO, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_ConsultingFeesIncurredToACompanyControlledByOurCooMember" xlink:to="lab_fil_ConsultingFeesIncurredToACompanyControlledByOurCooMember"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Net cash provided by financing activities </link:label>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US"> Net cash provided by financing activities </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:label="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Accrued interest on notes payable </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:to="lab_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Total assets </link:label>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US"> Total assets </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="lab_us-gaap_Assets"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
<link:label xlink:type="resource" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Address, City or Town </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
<link:label xlink:type="resource" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Address, Address Line Two </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Number of warrants outstanding </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_DueToACompanyOfWhichTheCooIsADirectorOfMember" xlink:label="fil_DueToACompanyOfWhichTheCooIsADirectorOfMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_DueToACompanyOfWhichTheCooIsADirectorOfMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Due to a company of which the COO is a director of </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_DueToACompanyOfWhichTheCooIsADirectorOfMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Due to a company of which the COO is a director of, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_DueToACompanyOfWhichTheCooIsADirectorOfMember" xlink:to="lab_fil_DueToACompanyOfWhichTheCooIsADirectorOfMember"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_DueToADirectorAndTheFormerCeoMember" xlink:label="fil_DueToADirectorAndTheFormerCeoMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_DueToADirectorAndTheFormerCeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Due to a director and the former CEO </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_DueToADirectorAndTheFormerCeoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Due to a director and the former CEO, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_DueToADirectorAndTheFormerCeoMember" xlink:to="lab_fil_DueToADirectorAndTheFormerCeoMember"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentAssetsTextBlock" xlink:label="us-gaap_OtherCurrentAssetsTextBlock"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_OtherCurrentAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Other Current Assets Disclosure </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCurrentAssetsTextBlock" xlink:to="lab_us-gaap_OtherCurrentAssetsTextBlock"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Net cash flows used in operating activities </link:label>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US"> Net cash flows used in operating activities </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Translation to reporting currency </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Shares issued on exercise of warrants and options, shares </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Equity Components [Axis] </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Foreign currency translation Income (loss) </link:label>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US"> Foreign currency translation Income (loss) </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalAndContractServicesExpense" xlink:label="us-gaap_ProfessionalAndContractServicesExpense"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ProfessionalAndContractServicesExpense" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Consulting fees </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalAndContractServicesExpense" xlink:to="lab_us-gaap_ProfessionalAndContractServicesExpense"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
<link:label xlink:type="resource" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Common Stock, Shares Outstanding </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ProceedsFromRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Related party payables, proceeds </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="lab_us-gaap_ProceedsFromRelatedPartyDebt"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Accrued interest </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_RoyaltyIncurredToACompanyOfWhichCooIsADirectorMember" xlink:label="fil_RoyaltyIncurredToACompanyOfWhichCooIsADirectorMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_RoyaltyIncurredToACompanyOfWhichCooIsADirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Royalty incurred to a company of which COO is a director </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_RoyaltyIncurredToACompanyOfWhichCooIsADirectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Royalty incurred to a company of which COO is a director, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_RoyaltyIncurredToACompanyOfWhichCooIsADirectorMember" xlink:to="lab_fil_RoyaltyIncurredToACompanyOfWhichCooIsADirectorMember"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Schedule of Warrant Details </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_DisclosureTextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Notes </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="lab_us-gaap_DisclosureTextBlockAbstract"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Shares issued on exercise of warrants and options, value </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Weighted Average Number of Shares Outstanding, Basic </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> CONDENSED CONSOLIDATED BALANCE SHEETS </link:label>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US"> CONDENSED CONSOLIDATED BALANCE SHEETS - Parenthetical </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
<link:label xlink:type="resource" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Local Phone Number </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
<link:label xlink:type="resource" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Registrant Name </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Stock options expired </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_RelatedPartyPayablesLoans" xlink:label="fil_RelatedPartyPayablesLoans"/>
<link:label xlink:type="resource" xlink:label="lab_fil_RelatedPartyPayablesLoans" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Related party loans </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_RelatedPartyPayablesLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the monetary amount of Related party payables, loans, as of the indicated date. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_RelatedPartyPayablesLoans" xlink:to="lab_fil_RelatedPartyPayablesLoans"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:label="us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Schedule of Revenue and Associated Costs </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:to="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Revenue Disclosure </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_NonCashIrFees" xlink:label="fil_NonCashIrFees"/>
<link:label xlink:type="resource" xlink:label="lab_fil_NonCashIrFees" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Non-cash IR fees </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_NonCashIrFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the monetary amount of Non-cash IR fees, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_NonCashIrFees" xlink:to="lab_fil_NonCashIrFees"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
<link:label xlink:type="resource" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Address, Address Line One </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_LoansOtherMember" xlink:label="fil_LoansOtherMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_LoansOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Loans, other </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_LoansOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Loans, other, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_LoansOtherMember" xlink:to="lab_fil_LoansOtherMember"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_SalesOfEbalanceDevicesMember" xlink:label="fil_SalesOfEbalanceDevicesMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_SalesOfEbalanceDevicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Sales of eBalance devices </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_SalesOfEbalanceDevicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Sales of eBalance devices, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_SalesOfEbalanceDevicesMember" xlink:to="lab_fil_SalesOfEbalanceDevicesMember"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Asset Class </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_ConsolidationOfLoans" xlink:label="fil_ConsolidationOfLoans"/>
<link:label xlink:type="resource" xlink:label="lab_fil_ConsolidationOfLoans" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Consolidation of loans </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_ConsolidationOfLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the monetary amount of Consolidation of loans, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_ConsolidationOfLoans" xlink:to="lab_fil_ConsolidationOfLoans"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Cash flows provided by financing activities </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Cash flows used in operating activities </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Equity Balance, Shares </link:label>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US"> Equity Balance, Shares </link:label>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US"> Equity Balance, Shares </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_Reserves1Member" xlink:label="fil_Reserves1Member"/>
<link:label xlink:type="resource" xlink:label="lab_fil_Reserves1Member" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Reserves {1} </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_Reserves1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US"> Reserves </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_Reserves1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Reserves, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_Reserves1Member" xlink:to="lab_fil_Reserves1Member"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Total liabilities and stockholders' deficit </link:label>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US"> Total liabilities and stockholders' deficit </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Total stockholders' deficit </link:label>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US"> Total stockholders' deficit </link:label>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US"> Equity Balance </link:label>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US"> Equity Balance </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Accumulated other comprehensive income/(loss) </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_Reserves" xlink:label="fil_Reserves"/>
<link:label xlink:type="resource" xlink:label="lab_fil_Reserves" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Reserves </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_Reserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the monetary amount of Reserves, as of the indicated date. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_Reserves" xlink:to="lab_fil_Reserves"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
<link:label xlink:type="resource" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Emerging Growth Company </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_LoansOther2Member" xlink:label="fil_LoansOther2Member"/>
<link:label xlink:type="resource" xlink:label="lab_fil_LoansOther2Member" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Loans, other2 </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_LoansOther2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Loans, other2, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_LoansOther2Member" xlink:to="lab_fil_LoansOther2Member"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Stock options expired, weighted avg exercise price </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Options outsanding, weighted average exercise price </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_N3RelatedPartyLoansPayableJeffsMember" xlink:label="fil_N3RelatedPartyLoansPayableJeffsMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_N3RelatedPartyLoansPayableJeffsMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> (3) Related Party Loans Payable - Jeffs </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_N3RelatedPartyLoansPayableJeffsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the (3) Related Party Loans Payable - Jeffs, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_N3RelatedPartyLoansPayableJeffsMember" xlink:to="lab_fil_N3RelatedPartyLoansPayableJeffsMember"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Comprehensive loss </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Net income (loss) </link:label>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US"> Net income (loss) for the period </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Current assets </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
<link:label xlink:type="resource" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Incorporation, State or Country Code </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
<link:label xlink:type="resource" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Document Transition Report </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_AdvancesFromDavidJeffsMember" xlink:label="fil_AdvancesFromDavidJeffsMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_AdvancesFromDavidJeffsMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Advances from David Jeffs </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_AdvancesFromDavidJeffsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Advances from David Jeffs, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_AdvancesFromDavidJeffsMember" xlink:to="lab_fil_AdvancesFromDavidJeffsMember"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_RelatedPartyAdvancesMember" xlink:label="fil_RelatedPartyAdvancesMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_RelatedPartyAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Related party advances </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_RelatedPartyAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Related party advances, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_RelatedPartyAdvancesMember" xlink:to="lab_fil_RelatedPartyAdvancesMember"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_RelatedPartyLoansPayableMember" xlink:label="fil_RelatedPartyLoansPayableMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_RelatedPartyLoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Related party loans payable </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_RelatedPartyLoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Related party loans payable, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_RelatedPartyLoansPayableMember" xlink:to="lab_fil_RelatedPartyLoansPayableMember"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_DueToVpOfTechnologyAndOperationsMember" xlink:label="fil_DueToVpOfTechnologyAndOperationsMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_DueToVpOfTechnologyAndOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Due to VP of Technology and Operations </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_DueToVpOfTechnologyAndOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Due to VP of Technology and Operations, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_DueToVpOfTechnologyAndOperationsMember" xlink:to="lab_fil_DueToVpOfTechnologyAndOperationsMember"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Related Party Transactions Disclosure </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Due to related parties: </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:to="lab_us-gaap_IncreaseDecreaseInDueToRelatedParties"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Retained Earnings </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Income Statement Location </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Common Stock, Shares, Issued </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Common Stock, Par or Stated Value Per Share </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_NotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Notes and advances payable </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="lab_us-gaap_NotesPayable"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Accounts payable </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
<link:label xlink:type="resource" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> City Area Code </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
<link:label xlink:type="resource" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Tax Identification Number </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport"/>
<link:label xlink:type="resource" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Document Quarterly Report </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_LoansToDavidJeffs2Member" xlink:label="fil_LoansToDavidJeffs2Member"/>
<link:label xlink:type="resource" xlink:label="lab_fil_LoansToDavidJeffs2Member" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Loans to david Jeffs2 </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_LoansToDavidJeffs2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Loans to david Jeffs2, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_LoansToDavidJeffs2Member" xlink:to="lab_fil_LoansToDavidJeffs2Member"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:label="us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Deferred Bonus and Profit Sharing Arrangement, Individual Contract, Type of Deferred Compensation </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:to="lab_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Warrants exercised </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Effective interest rate </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_DueToTheCeoMember" xlink:label="fil_DueToTheCeoMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_DueToTheCeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Due to the CEO </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_DueToTheCeoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Due to the CEO, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_DueToTheCeoMember" xlink:to="lab_fil_DueToTheCeoMember"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ProceedsFromNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Proceeds from notes payable </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="lab_us-gaap_ProceedsFromNotesPayable"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Accrued liabilities: </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Equity Component </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> AOCI Attributable to Parent </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Cost of goods sold </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Statement [Line Items] </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesMember" xlink:label="us-gaap_SalesMember"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Sales </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesMember" xlink:to="lab_us-gaap_SalesMember"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Statement </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> STOCKHOLDERS' DEFICIT </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
<link:label xlink:type="resource" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Document Type </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="lab_dei_DocumentType"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_BrekTechMember" xlink:label="fil_BrekTechMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_BrekTechMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Brek Tech </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_BrekTechMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Brek Tech, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_BrekTechMember" xlink:to="lab_fil_BrekTechMember"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_ConsultingFeesIncurredToTheVpOfTechnologyAndOperationsMember" xlink:label="fil_ConsultingFeesIncurredToTheVpOfTechnologyAndOperationsMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_ConsultingFeesIncurredToTheVpOfTechnologyAndOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Consulting fees incurred to the VP of Technology and Operations </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_ConsultingFeesIncurredToTheVpOfTechnologyAndOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Consulting fees incurred to the VP of Technology and Operations, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_ConsultingFeesIncurredToTheVpOfTechnologyAndOperationsMember" xlink:to="lab_fil_ConsultingFeesIncurredToTheVpOfTechnologyAndOperationsMember"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_DueToACompanyControlledByTheCooAndAMajorShareholderMember" xlink:label="fil_DueToACompanyControlledByTheCooAndAMajorShareholderMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_DueToACompanyControlledByTheCooAndAMajorShareholderMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Due to a company controlled by the COO and a major shareholder </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_DueToACompanyControlledByTheCooAndAMajorShareholderMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Due to a company controlled by the COO and a major shareholder, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_DueToACompanyControlledByTheCooAndAMajorShareholderMember" xlink:to="lab_fil_DueToACompanyControlledByTheCooAndAMajorShareholderMember"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Change in book value of the equipment </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Schedule of Amounts Due to Related Parties </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Effects of foreign currency exchange on cash </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Other current assets: </link:label>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US"> Other current assets: </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Revenue </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Common Stock, Shares Authorized </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Additional paid-in capital </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> ASSETS </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
<link:label xlink:type="resource" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Shell Company </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_WarrantsGrantedJan2920201Member" xlink:label="fil_WarrantsGrantedJan2920201Member"/>
<link:label xlink:type="resource" xlink:label="lab_fil_WarrantsGrantedJan2920201Member" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Warrants Granted Jan 29, 2020(1) </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_WarrantsGrantedJan2920201Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Warrants Granted Jan 29, 2020(1), during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_WarrantsGrantedJan2920201Member" xlink:to="lab_fil_WarrantsGrantedJan2920201Member"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_MonthlySubscMember" xlink:label="fil_MonthlySubscMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_MonthlySubscMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Monthly subscriptions </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_MonthlySubscMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Monthly subscriptions, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_MonthlySubscMember" xlink:to="lab_fil_MonthlySubscMember"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_ReceivablesAssociatedWithGstCellMedxCanadaMember" xlink:label="fil_ReceivablesAssociatedWithGstCellMedxCanadaMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_ReceivablesAssociatedWithGstCellMedxCanadaMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Receivables associated with GST Cell MedX Canada </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_ReceivablesAssociatedWithGstCellMedxCanadaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Receivables associated with GST Cell MedX Canada, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_ReceivablesAssociatedWithGstCellMedxCanadaMember" xlink:to="lab_fil_ReceivablesAssociatedWithGstCellMedxCanadaMember"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Schedule of Stock Option Activity </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Schedule of Loans and Advances Outstanding to Related Parties </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TableTextBlockSupplementAbstract" xlink:label="us-gaap_TableTextBlockSupplementAbstract"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_TableTextBlockSupplementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Tables/Schedules </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TableTextBlockSupplementAbstract" xlink:to="lab_us-gaap_TableTextBlockSupplementAbstract"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Research and development costs </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_DueToRelatedPartyCurrent" xlink:label="fil_DueToRelatedPartyCurrent"/>
<link:label xlink:type="resource" xlink:label="lab_fil_DueToRelatedPartyCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Due to related parties - current </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_DueToRelatedPartyCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the monetary amount of Due to related parties - current, as of the indicated date. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_DueToRelatedPartyCurrent" xlink:to="lab_fil_DueToRelatedPartyCurrent"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Deferred Bonus and Profit Sharing Arrangements, Individual Contracts, Type of Deferred Compensation [Axis] </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Equipment, book value </link:label>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US"> Equipment, book value </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_LoansToACompanyDavidJeffsIsADirectorOfMember" xlink:label="fil_LoansToACompanyDavidJeffsIsADirectorOfMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_LoansToACompanyDavidJeffsIsADirectorOfMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Loans to a company David Jeffs is a director of </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_LoansToACompanyDavidJeffsIsADirectorOfMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Loans to a company David Jeffs is a director of, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_LoansToACompanyDavidJeffsIsADirectorOfMember" xlink:to="lab_fil_LoansToACompanyDavidJeffsIsADirectorOfMember"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_ManagementFeesIncurredToTheCfoMember" xlink:label="fil_ManagementFeesIncurredToTheCfoMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_ManagementFeesIncurredToTheCfoMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Management fees incurred to the CFO </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_ManagementFeesIncurredToTheCfoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Management fees incurred to the CFO, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_ManagementFeesIncurredToTheCfoMember" xlink:to="lab_fil_ManagementFeesIncurredToTheCfoMember"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_ScheduleOfWarrantActivityTextBlock" xlink:label="fil_ScheduleOfWarrantActivityTextBlock"/>
<link:label xlink:type="resource" xlink:label="lab_fil_ScheduleOfWarrantActivityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Schedule of Warrant Activity </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_ScheduleOfWarrantActivityTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the textual narrative disclosure of Schedule of Warrant Activity, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_ScheduleOfWarrantActivityTextBlock" xlink:to="lab_fil_ScheduleOfWarrantActivityTextBlock"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Share Capital Disclosure </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Proceeds from subscription to shares </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Liabilities {1} </link:label>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US"> Liabilities </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
<link:label xlink:type="resource" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Current Reporting Status </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
<link:label xlink:type="resource" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Address, State or Province </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
<link:label xlink:type="resource" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Document Period End Date </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Warrants expired </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_CostOfEbalanceDevicesMember" xlink:label="fil_CostOfEbalanceDevicesMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_CostOfEbalanceDevicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Cost of eBalance devices </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_CostOfEbalanceDevicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Cost of eBalance devices, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_CostOfEbalanceDevicesMember" xlink:to="lab_fil_CostOfEbalanceDevicesMember"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_ForeignExchangeEquipmentGL" xlink:label="fil_ForeignExchangeEquipmentGL"/>
<link:label xlink:type="resource" xlink:label="lab_fil_ForeignExchangeEquipmentGL" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Foreign exchange gain (loss), equipment </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_ForeignExchangeEquipmentGL" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Foreign exchange gain (loss), equipment </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_ForeignExchangeEquipmentGL" xlink:to="lab_fil_ForeignExchangeEquipmentGL"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Stock issued for cash, shares </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Revenues </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_NotesAndAdvancesDueToRelatedParties" xlink:label="fil_NotesAndAdvancesDueToRelatedParties"/>
<link:label xlink:type="resource" xlink:label="lab_fil_NotesAndAdvancesDueToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Notes and advances due to related parties </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_NotesAndAdvancesDueToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the monetary amount of Notes and advances due to related parties, as of the indicated date. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_NotesAndAdvancesDueToRelatedParties" xlink:to="lab_fil_NotesAndAdvancesDueToRelatedParties"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Other current assets </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
<link:label xlink:type="resource" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Document Fiscal Year Focus </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
<link:label xlink:type="resource" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Small Business </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
<link:label xlink:type="resource" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Address, Postal Zip Code </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Stock options outstanding </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_PrepaidExpensesMember" xlink:label="fil_PrepaidExpensesMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_PrepaidExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Prepaid expenses </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_PrepaidExpensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Prepaid expenses, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_PrepaidExpensesMember" xlink:to="lab_fil_PrepaidExpensesMember"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_LoanAgreementWithMrHargreavesTheCompanySDirectorAndVpOfTechnologyAndOperationsMember" xlink:label="fil_LoanAgreementWithMrHargreavesTheCompanySDirectorAndVpOfTechnologyAndOperationsMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_LoanAgreementWithMrHargreavesTheCompanySDirectorAndVpOfTechnologyAndOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> loan agreement with Mr. Hargreaves, the Company's director and VP of Technology and Operations </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_LoanAgreementWithMrHargreavesTheCompanySDirectorAndVpOfTechnologyAndOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the loan agreement with Mr. Hargreaves, the Company's director and VP of Technology and Operations, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_LoanAgreementWithMrHargreavesTheCompanySDirectorAndVpOfTechnologyAndOperationsMember" xlink:to="lab_fil_LoanAgreementWithMrHargreavesTheCompanySDirectorAndVpOfTechnologyAndOperationsMember"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_DueToACompanyControlledByOurCooMember" xlink:label="fil_DueToACompanyControlledByOurCooMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_DueToACompanyControlledByOurCooMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Due to a company controlled by our COO </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_DueToACompanyControlledByOurCooMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Due to a company controlled by our COO, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_DueToACompanyControlledByOurCooMember" xlink:to="lab_fil_DueToACompanyControlledByOurCooMember"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_DueToCfoMember" xlink:label="fil_DueToCfoMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_DueToCfoMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Due to CFO </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_DueToCfoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Due to CFO, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_DueToCfoMember" xlink:to="lab_fil_DueToCfoMember"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Related Party Transaction [Axis] </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Equipment Disclosure </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Interest </link:label>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US"> Interest </link:label>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US"> Interest expense </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Gross margin </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Total liabilities </link:label>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US"> Total liabilities </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Cash </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="lab_us-gaap_Cash"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_NotesAndAdvancesNotRelatedMember" xlink:label="fil_NotesAndAdvancesNotRelatedMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_NotesAndAdvancesNotRelatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Notes and advances, not related </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_NotesAndAdvancesNotRelatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Notes and advances, not related, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_NotesAndAdvancesNotRelatedMember" xlink:to="lab_fil_NotesAndAdvancesNotRelatedMember"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="us-gaap_ShortTermDebtTypeDomain"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Short-Term Debt, Type </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Short-Term Debt, Type [Axis] </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_RoyaltyIncurredToACompanyControlledByTheCooAndAMajorShareholderMember" xlink:label="fil_RoyaltyIncurredToACompanyControlledByTheCooAndAMajorShareholderMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_RoyaltyIncurredToACompanyControlledByTheCooAndAMajorShareholderMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Royalty incurred to a company controlled by the COO and a major shareholder </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_RoyaltyIncurredToACompanyControlledByTheCooAndAMajorShareholderMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Royalty incurred to a company controlled by the COO and a major shareholder, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_RoyaltyIncurredToACompanyControlledByTheCooAndAMajorShareholderMember" xlink:to="lab_fil_RoyaltyIncurredToACompanyControlledByTheCooAndAMajorShareholderMember"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Related Party Transaction </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Cash, beginning </link:label>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US"> Cash, beginning </link:label>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US"> Cash, ending </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Accounts payable: </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Changes in operating assets and liabilities </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Shares issued for services, shares </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Common Stock </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Accrued liabilities </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Amortization {1} </link:label>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US"> Amortization </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Accrued interest payable </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_InterestPayableCurrentAndNoncurrent"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_RelatedPartyLoansPayableMrsJeffsMember" xlink:label="fil_RelatedPartyLoansPayableMrsJeffsMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_RelatedPartyLoansPayableMrsJeffsMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Related Party Loans Payable - Mrs. Jeffs </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_RelatedPartyLoansPayableMrsJeffsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Related Party Loans Payable - Mrs. Jeffs, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_RelatedPartyLoansPayableMrsJeffsMember" xlink:to="lab_fil_RelatedPartyLoansPayableMrsJeffsMember"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_RelatedPartyLoanSecuredRichardJeffsMember" xlink:label="fil_RelatedPartyLoanSecuredRichardJeffsMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_RelatedPartyLoanSecuredRichardJeffsMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Related Party Loan, secured - Richard Jeffs </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_RelatedPartyLoanSecuredRichardJeffsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Related Party Loan, secured - Richard Jeffs, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_RelatedPartyLoanSecuredRichardJeffsMember" xlink:to="lab_fil_RelatedPartyLoanSecuredRichardJeffsMember"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_ScheduleOfTransactionsWithRelatedPartiesTextBlock" xlink:label="fil_ScheduleOfTransactionsWithRelatedPartiesTextBlock"/>
<link:label xlink:type="resource" xlink:label="lab_fil_ScheduleOfTransactionsWithRelatedPartiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Schedule of Transactions with Related Parties </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_ScheduleOfTransactionsWithRelatedPartiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Tabular Disclosure </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_ScheduleOfTransactionsWithRelatedPartiesTextBlock" xlink:to="lab_fil_ScheduleOfTransactionsWithRelatedPartiesTextBlock"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Notes and Advances Payable Disclosure, Current </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentForAmortization" xlink:label="us-gaap_AdjustmentForAmortization"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Amortization </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Operating expenses </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Common stock, $0.001 par value, 300,000,000 shares authorized; 62,923,063 shares issued and outstanding at November 30, 2022 and May 31, 2022 </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> LIABILITIES AND STOCKHOLDERS' DEFICIT </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
<link:label xlink:type="resource" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity File Number </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_TextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Details </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TextBlockAbstract" xlink:to="lab_us-gaap_TextBlockAbstract"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_RoyaltyPayableForEbalanceDevicesMember" xlink:label="fil_RoyaltyPayableForEbalanceDevicesMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_RoyaltyPayableForEbalanceDevicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Royalty payable for eBalance devices </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_RoyaltyPayableForEbalanceDevicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Royalty payable for eBalance devices, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_RoyaltyPayableForEbalanceDevicesMember" xlink:to="lab_fil_RoyaltyPayableForEbalanceDevicesMember"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Asset Class [Axis] </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtPercentageBearingFixedInterestRate" xlink:label="us-gaap_ShortTermDebtPercentageBearingFixedInterestRate"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_ShortTermDebtPercentageBearingFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Annual interest rate - debt </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtPercentageBearingFixedInterestRate" xlink:to="lab_us-gaap_ShortTermDebtPercentageBearingFixedInterestRate"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_AdvancesDaCostaManagementMember" xlink:label="fil_AdvancesDaCostaManagementMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_AdvancesDaCostaManagementMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Advances, Da Costa Management </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_AdvancesDaCostaManagementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Advances, Da Costa Management, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_AdvancesDaCostaManagementMember" xlink:to="lab_fil_AdvancesDaCostaManagementMember"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpensesRelatedParty" xlink:label="us-gaap_CostsAndExpensesRelatedParty"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_CostsAndExpensesRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Transactions with related parties </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesRelatedParty" xlink:to="lab_us-gaap_CostsAndExpensesRelatedParty"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_ManagementFeesIncurredToADirectorAndTheFormerCeoMember" xlink:label="fil_ManagementFeesIncurredToADirectorAndTheFormerCeoMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_ManagementFeesIncurredToADirectorAndTheFormerCeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Management fees incurred to a director and the former CEO </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_ManagementFeesIncurredToADirectorAndTheFormerCeoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Management fees incurred to a director and the former CEO, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_ManagementFeesIncurredToADirectorAndTheFormerCeoMember" xlink:to="lab_fil_ManagementFeesIncurredToADirectorAndTheFormerCeoMember"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_ManagementFeesIncurredToACeoMember" xlink:label="fil_ManagementFeesIncurredToACeoMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_ManagementFeesIncurredToACeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Management fees incurred the CEO </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_ManagementFeesIncurredToACeoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Management fees incurred the CEO, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_ManagementFeesIncurredToACeoMember" xlink:to="lab_fil_ManagementFeesIncurredToACeoMember"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Subsequent Events Disclosure </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Notes and Advances Payable Disclosure </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Organization and Nature of Operations </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Shares issued for services, value </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Additional Paid-in Capital </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Earnings Per Share, Basic </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Other items </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Total operating expenses </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> General and administrative expenses </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Income Statement Location [Axis] </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Accumulated deficit </link:label>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US"> Accumulated deficit </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
<link:label xlink:type="resource" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Document Fiscal Period Focus </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
<link:label xlink:type="resource" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Filer Category </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
<link:label xlink:type="resource" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Entity Interactive Data Current </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
<link:label xlink:type="resource" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Registrant CIK </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_NumberOfWarrantsExercisable" xlink:label="fil_NumberOfWarrantsExercisable"/>
<link:label xlink:type="resource" xlink:label="lab_fil_NumberOfWarrantsExercisable" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Number of warrants exercisable </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_NumberOfWarrantsExercisable" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Number of warrants exercisable </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_NumberOfWarrantsExercisable" xlink:to="lab_fil_NumberOfWarrantsExercisable"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_LoansToDavidJeffsMember" xlink:label="fil_LoansToDavidJeffsMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_LoansToDavidJeffsMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Loans to David Jeffs </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_LoansToDavidJeffsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Loans to David Jeffs, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_LoansToDavidJeffsMember" xlink:to="lab_fil_LoansToDavidJeffsMember"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_RelatedPartyLoanUnsecuredRichardJeffsMember" xlink:label="fil_RelatedPartyLoanUnsecuredRichardJeffsMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_RelatedPartyLoanUnsecuredRichardJeffsMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Related Party Loan, unsecured - Richard Jeffs </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_RelatedPartyLoanUnsecuredRichardJeffsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Related Party Loan, unsecured - Richard Jeffs, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_RelatedPartyLoanUnsecuredRichardJeffsMember" xlink:to="lab_fil_RelatedPartyLoanUnsecuredRichardJeffsMember"/>
<link:loc xlink:type="locator" xlink:href="cmxc-20221130.xsd#fil_CellMedxCanadaLoansToMrJeffsMember" xlink:label="fil_CellMedxCanadaLoansToMrJeffsMember"/>
<link:label xlink:type="resource" xlink:label="lab_fil_CellMedxCanadaLoansToMrJeffsMember" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Cell MedX Canada loans to Mr. Jeffs </link:label>
<link:label xlink:type="resource" xlink:label="lab_fil_CellMedxCanadaLoansToMrJeffsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US"> Represents the Cell MedX Canada loans to Mr. Jeffs, during the indicated time period. </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="fil_CellMedxCanadaLoansToMrJeffsMember" xlink:to="lab_fil_CellMedxCanadaLoansToMrJeffsMember"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Increase/(decrease) in cash </link:label>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US"> Increase/(decrease) in cash </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:label="us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Unrealized foreign exchange </link:label>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US"> Unrealized foreign exchange </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:to="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Adjustments to reconcile net loss to net cash used in operating activities </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Stock issued for cash, value </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
<link:label xlink:type="resource" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
<link:label xlink:type="resource" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Amendment Flag </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
<link:label xlink:type="resource" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US"> Fiscal Year End </link:label>
<link:labelArc order="1.0" xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate"/>
</link:labelLink>
</link:linkbase>

5 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/15/24  Cell MedX Corp.                   10-Q        2/29/24   53:2.7M                                   Empire Stock Transf… Inc
 1/16/24  Cell MedX Corp.                   10-Q       11/30/23   46:2.3M                                   Empire Stock Transf… Inc
10/16/23  Cell MedX Corp.                   10-Q        8/31/23   42:1.9M                                   Empire Stock Transf… Inc
 9/01/23  Cell MedX Corp.                   10-K        5/31/23   73:3.2M                                   Empire Stock Transf… Inc
 6/29/23  Cell MedX Corp.                   10-Q        2/28/23   53:2.5M                                   Empire Stock Transf… Inc

21 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/07/23  Cell MedX Corp.                   10-K        5/31/22   90:3.6M                                   Empire Stock Transf… Inc
10/18/22  Cell MedX Corp.                   8-K:1,7,8,910/11/22   17:284K                                   Empire Stock Transf… Inc
 1/12/22  Cell MedX Corp.                   10-Q       11/30/21   54:2.4M                                   Empire Stock Transf… Inc
 8/30/21  Cell MedX Corp.                   10-K        5/31/21   83:3.7M                                   Empire Stock Transf… Inc
 5/26/21  Cell MedX Corp.                   8-K:1,3,7,9 5/24/21    4:95K                                    Empire Stock Transf… Inc
 4/09/21  Cell MedX Corp.                   10-Q        2/28/21   56:2.8M                                   Empire Stock Transf… Inc
 1/14/21  Cell MedX Corp.                   10-Q       11/30/20   53:2M                                     Empire Stock Transf… Inc
 9/15/20  Cell MedX Corp.                   10-K        5/31/20   84:2.9M                                   Empire Stock Transf… Inc
 4/14/20  Cell MedX Corp.                   10-Q        2/29/20   67:2.2M                                   Empire Stock Transf… Inc
 1/31/20  Cell MedX Corp.                   8-K:1,9     1/29/20    3:69K                                    Empire Stock Transf… Inc
 1/14/20  Cell MedX Corp.                   10-Q       11/30/19   65:2.2M                                   Empire Stock Transf… Inc
12/31/18  Cell MedX Corp.                   8-K:1,3,9  12/27/18    3:248K                                   Empire Stock Transf… Inc
 9/13/18  Cell MedX Corp.                   10-K        5/31/18   85:3M                                     Empire Stock Transf… Inc
10/17/17  Cell MedX Corp.                   10-Q        8/31/17   59:2.2M                                   Empire Stock Transf… Inc
 8/11/15  Cell MedX Corp.                   8-K:5,9     8/11/15    3:172K                                   Ideal Connection, Inc/FA
11/18/14  Cell MedX Corp.                   8-K:1,9    11/13/14    2:48K                                    Ideal Connection, Inc/FA
11/03/14  Cell MedX Corp.                   8-K:1,9    10/28/14    2:60K                                    Ideal Connection, Inc/FA
10/17/14  Cell MedX Corp.                   8-K:1,9    10/16/14    3:407K                                   Ideal Connection, Inc/FA
10/09/14  Cell MedX Corp.                   10-Q        8/31/14   37:2.9M                                   Ideal Connection, Inc/FA
10/13/10  Cell MedX Corp.                   S-1/A                  8:1.2M                                   Toppan Merrill/FA
 7/13/10  Cell MedX Corp.                   S-1                   11:921K                                   Toppan Merrill/FA
↑Top
Filing Submission 0001393905-23-000233   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Fri., May 10, 3:51:42.3am ET